Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3756447

CCC(N)(Cc1ccccc1)c1ccccc1.Cl

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A2 known ✓ P23975 1/20 0.52
KCNA5 known ✓ P22460 1/20 0.40
MAOA known ✓ P21397 2/20 0.38
MAOB known ✓ P27338 2/20 0.38
TAAR1 Q96RJ0 2/20 0.52
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.42
HIF1A Q16665 1/20 0.42
MAPK1 P28482 1/20 0.41
KIF11 P52732 2/20 0.41
LMNA P02545 1/20 0.39
CYP2D6 P10635 1/20 0.39
TP53 P04637 1/20 0.39
KCNN4 O15554 1/20 0.39
CYP3A4 P08684 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7275224 0.98 TAAR1 (0.54) TAAR1SLC6A2CYP1A2CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL11785557 0.87 SLC6A2 (0.54) TAAR1SLC6A2CYP1A2CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL890979 0.85 KCNN4 (0.48) TAAR1SLC6A2CYP1A2SMN1; SMN2MAPK1
SCHEMBL2406230 0.85 SLC6A2 (0.56) TAAR1SLC6A2CYP1A2CYP2C9CYP2C19
SCHEMBL141471 0.83 KCNN4 (0.50) TAAR1SLC6A2CYP1A2MAPK1KIF11
Hydrochloric Acid SCHEMBL7677659 0.82 TAAR1 (0.48) TAAR1SLC6A2CYP1A2CYP2C9CYP2C19
Bromide SCHEMBL11663273 0.81 KCNN4 (0.48) TAAR1SLC6A2CYP1A2MAPK1KIF11
SCHEMBL9584692 0.79 TAAR1 (0.50) TAAR1SLC6A2CYP1A2CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL14833269 0.78 KCNN4 (0.41) TAAR1SLC6A2CYP1A2SMN1; SMN2KIF11
Hydrochloric Acid SCHEMBL7033437 0.77 SLC6A2 (0.58) TAAR1SLC6A2CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4181676-A1 DISINFECTANT/SANITIZER SOLUTIONS Sterilex LLC (US) 2023-05-24 EP disclosed
WO-2022016069-A1 DISINFECTANT/SANITIZER SOLUTIONS STERILEX, LLC (US) 2022-01-20 WO disclosed
US-20220015359-A1 DISINFECTANT/SANITIZER SOLUTIONS ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT 2022-01-20 US disclosed
US-20210079319-A1 AMBIENT MOISTURE-ACTIVATED HARD SURFACE TREATMENT POWDER ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT 2021-03-18 US disclosed
US-10851328-B2 Ambient moisture-activated hard surface treatment powder STERILEX, LLC (US) 2020-12-01 US disclosed
US-20200061224-A1 ALUMINUM-COMPATIBLE COMPOSITIONS FOR 2-PART ALKALINE DISINFECTANTS AND SANITIZERS Sterilex LLC (US) 2020-02-27 US disclosed
EP-3529343-A1 AMBIENT MOISTURE-ACTIVATED SURFACE TREATMENT POWDER Sterilex LLC (US) 2019-08-28 EP disclosed
US-20190136158-A1 AMBIENT MOISTURE-ACTIVATED HARD SURFACE TREATMENT POWDER ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT 2019-05-09 US disclosed
US-10053653-B2 Ambient moisture-activated hard surface treatment powder STERILEX, LLC (US) 2018-08-21 US disclosed
WO-2018075604-A1 AMBIENT MOISTURE-ACTIVATED SURFACE TREATMENT POWDER Sterilex LLC (US) 2018-04-26 WO disclosed
US-8778370-B2 Method and composition for inhibiting growth of microorganisms in industrial process waters in the presence of anionic anti-fouling additives STERILEX CORPORATION (US) 2014-07-15 US disclosed
US-20100183738-A1 METHOD AND COMPOSITION FOR INHIBITING GROWTH OF MICROORGANISMS IN INDUSTRIAL PROCESS WATERS IN THE PRESENCE OF ANIONIC ANTI-FOULING ADDITIVES ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT 2010-07-22 US disclosed
US-5382683-A 2-aminopropanamide derivatives FISONS CORPORATION (US) 1995-01-17 US disclosed
EP-0326240-B1 2-Amino acetamide derivatives FISONS CORP (US) 1993-10-20 EP disclosed
US-5093524-A 2-(alkylamino)acetamide derivatives FISONS CORPORATION (US) 1992-03-03 US disclosed
EP-0279937-B1 2-AMINOACETAMIDE DERIVATIVES FISONS CORPORATION (US) 1991-10-09 EP disclosed
EP-0401253-A1 2-AMINO ACETAMIDE DERIVATIVES FISONS CORPORATION (US) 1990-12-12 EP disclosed
EP-0326240-A1 2-Amino acetamide derivatives FISONS CORPORATION (US) 1989-08-02 EP disclosed
WO-1989006646-A1 2-AMINO ACETAMIDE DERIVATIVES FISONS CORPORATION (US) 1989-07-27 WO disclosed
EP-0279937-A1 2-Aminoacetamide derivatives FISONS CORPORATION (US) 1988-08-31 EP disclosed